D. Sobot

Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery

P. Couvreur, A. Klymchenko, S. Yesylevskyy, 2017, Nature Communications.

Circulating Lipoproteins: A Trojan Horse Guiding Squalenoylated Drugs to LDL-Accumulating Cancer Cells.

M. Windbergs, P. Couvreur, S. Mura, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Transport Mechanisms of Squalenoyl-Adenosine Nanoparticles Across the Blood–Brain Barrier

P. Couvreur, K. Braeckmans, V. Nicolas, 2015 .

Synthesis of a deuterated probe for the confocal Raman microscopy imaging of squalenoyl nanomedicines

M. Windbergs, P. Couvreur, S. Mura, 2016, Beilstein journal of organic chemistry.

Squalene versus cholesterol: Which is the best nanocarrier for the delivery to cells of the anticancer drug gemcitabine?

P. Couvreur, S. Yesylevskyy, C. Ramseyer, 2018, Comptes Rendus Chimie.

How can nanomedicines overcome cellular-based anticancer drug resistance?

P. Couvreur, S. Mura, D. Sobot, 2016, Journal of materials chemistry. B.

In vitro investigation of multidrug nanoparticles for combined therapy with gemcitabine and a tyrosine kinase inhibitor: Together is not better.

P. Couvreur, B. Stella, S. Mura, 2016, Biochimie.

Quality of pork carcass on the slaughter line in mini slaughterhouses.

D. Sobot, A. Šobot, 2014 .

In Vivo FRET Imaging to Predict the Risk Associated with Hepatic Accumulation of Squalene‐Based Prodrug Nanoparticles

P. Couvreur, A. Klymchenko, S. Mura, 2018, Advanced healthcare materials.